{"id":160170,"date":"2026-11-13T01:01:06","date_gmt":"2026-11-13T01:01:06","guid":{"rendered":"http:\/\/cryptospotters.net\/?p=160170"},"modified":"2026-11-13T01:01:06","modified_gmt":"2026-11-13T01:01:06","slug":"eli-lilly-beats-novo-nordisk-to-china-approval-for-first-oral-glp-1-weight-loss-drug","status":"publish","type":"post","link":"http:\/\/cryptospotters.net\/?p=160170","title":{"rendered":"Eli Lilly beats Novo Nordisk to China approval for first oral GLP-1 weight-loss drug"},"content":{"rendered":"<p>Source: Tech &#8211; South China Morning PostChina has approved US pharmaceutical giant Eli Lilly\u2019s weight-loss pill orforglipron, making it the country\u2019s first available oral GLP-1 treatment for obesity as global drug makers seek to tap the country\u2019s massive weight-management market.<br \/>\nChina\u2019s National Medical Products Administration announced the approval on Thursday, saying that the once-daily pill, marketed as Foundayo, could be used for chronic weight management by obese or overweight adults.<br \/>\nGLP-1 receptor agonists are synthetic&#8230;<a href=\"https:\/\/www.scmp.com\/business\/companies\/article\/3374229\/eli-lilly-beats-novo-nordisk-china-approval-first-oral-glp-1-weight-loss-drug\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Source: Tech &#8211; South China Morning PostChina has approved US pharmaceutical giant Eli Lilly\u2019s weight-loss pill orforglipron, making it the country\u2019s first available oral GLP-1 treatment for obesity as global&hellip; <\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[4],"tags":[],"_links":{"self":[{"href":"http:\/\/cryptospotters.net\/index.php?rest_route=\/wp\/v2\/posts\/160170"}],"collection":[{"href":"http:\/\/cryptospotters.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/cryptospotters.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"http:\/\/cryptospotters.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=160170"}],"version-history":[{"count":0,"href":"http:\/\/cryptospotters.net\/index.php?rest_route=\/wp\/v2\/posts\/160170\/revisions"}],"wp:attachment":[{"href":"http:\/\/cryptospotters.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=160170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/cryptospotters.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=160170"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/cryptospotters.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=160170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}